GSK is to spend over US $1 billion to increase its stakes in its consumer healthcare subsidiaries in India and Nigeria. GSK will increase its share of its publicly-listed Consumer Healthcare ...
According to these people, the company, promoted by former Metropolis cofounder GSK Velu, will use the proceeds ... ability ...
GlaxoSmithKline Pharmaceuticals ... which derives most of its revenue from India, continued to grapple with challenges following the inclusion of its key products such as Ceftum antibiotic ...
At the second edition of Next Gen LabCon organized by ET Pharma in Hyderabad, pharma leaders highlighted the significant growth potential of India’s CDMO (contract development and manufacturing ...
India's Intellectual Property Appellate Board (IPAB) has revoked the patent for global pharmaceutical company, GlaxoSmithKline's anti-cancer drug Tykerb. Tykerb (lapatinib) is a dual tyrosine ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main ...
GSK Pharma board approves sale of Vemgal plant ... its global pipeline in areas like respiratory drugs and vaccines in India. Apex Labs pioneered the introduction of zinc-based formulations ...
New Delhi, Mar 3 () Drug firm GlaxoSmithKline Pharmaceuticals on Tuesday said it has appointed Sridhar Venkatesh as managing director & vice president of GSK India, effective April 1, 2020.
Paid and presented by GSK. The village of Biturli, India is surrounded by four dams – and yet, it’s one of many water-stressed communities due to the extremes of climate change. Discover how a ...
The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...
GlaxoSmithKline Pharmaceuticals Ltd. (‘GSK India’) announces completion of its transaction with Novartis Healthcare Pvt. Ltd. ... GSK Pharma's Bengaluru facility to be operational by 2017 The ...